Corentec Co Ltd (104540) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Corentec Co Ltd (104540) has a cash flow conversion efficiency ratio of 0.100x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.50 Billion ≈ $5.76 Million USD) by net assets (₩85.14 Billion ≈ $57.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Corentec Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Corentec Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Corentec Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Corentec Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Corentec Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nam Liong Global Corp
TWO:5450
|
0.048x |
|
Bingshan Refrigeration and Heat Transfer Technologies Co Ltd
SHE:200530
|
0.058x |
|
Poh Huat Resources Holdings
KLSE:7088
|
0.049x |
|
Leviathan Gold Ltd
V:LVX
|
-0.103x |
|
Birla Cable Limited
NSE:BIRLACABLE
|
-0.019x |
|
IRSA Propiedades Comerciales S.A
BA:IRCP
|
0.019x |
|
Suparma Tbk
JK:SPMA
|
0.049x |
|
Entera Bio Ltd
NASDAQ:ENTX
|
-0.180x |
Annual Cash Flow Conversion Efficiency for Corentec Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Corentec Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Corentec Co Ltd (104540) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩71.98 Billion ≈ $48.78 Million |
₩-6.61 Billion ≈ $-4.48 Million |
-0.092x | -400.04% |
| 2023-12-31 | ₩86.12 Billion ≈ $58.36 Million |
₩2.63 Billion ≈ $1.79 Million |
0.031x | -81.03% |
| 2022-12-31 | ₩65.75 Billion ≈ $44.56 Million |
₩10.60 Billion ≈ $7.18 Million |
0.161x | +124.02% |
| 2021-12-31 | ₩56.63 Billion ≈ $38.38 Million |
₩4.08 Billion ≈ $2.76 Million |
0.072x | +192.57% |
| 2020-12-31 | ₩46.41 Billion ≈ $31.45 Million |
₩-3.61 Billion ≈ $-2.44 Million |
-0.078x | -160.37% |
| 2019-12-31 | ₩29.94 Billion ≈ $20.29 Million |
₩3.86 Billion ≈ $2.61 Million |
0.129x | -41.02% |
| 2018-12-31 | ₩24.09 Billion ≈ $16.32 Million |
₩5.26 Billion ≈ $3.56 Million |
0.218x | +102.32% |
| 2017-12-31 | ₩54.32 Billion ≈ $36.81 Million |
₩5.86 Billion ≈ $3.97 Million |
0.108x | +120.77% |
| 2016-12-31 | ₩60.18 Billion ≈ $40.79 Million |
₩2.94 Billion ≈ $1.99 Million |
0.049x | +8.09% |
| 2015-12-31 | ₩56.27 Billion ≈ $38.13 Million |
₩2.54 Billion ≈ $1.72 Million |
0.045x | +384.68% |
| 2014-12-31 | ₩48.30 Billion ≈ $32.73 Million |
₩450.70 Million ≈ $305.43K |
0.009x | -60.24% |
| 2013-12-31 | ₩44.48 Billion ≈ $30.15 Million |
₩1.04 Billion ≈ $707.46K |
0.023x | -- |
About Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more